Large study tracks antibody risk in pregnant women to prevent newborn bleeding
NCT ID NCT05345561
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed over 14,000 pregnant women to see how many are at risk for a condition called FNAIT, where a mother's immune system attacks her baby's platelets, causing dangerous bleeding. Researchers measured how often women develop specific antibodies (HPA-1a) and looked at pregnancy outcomes. No treatments were given; the goal was simply to gather information to better understand who is at risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barnmorskestationen Rosengård
Lund, Skåne County, 222 42, Sweden
-
Clinical Trial Consultants - Uppsala
Uppsala, Uppsala Ian, 752 37, Sweden
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Cooper University Hospital
Camden, New Jersey, 08103, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Javara Inc. - Forest
Dallas, Texas, 75230, United States
-
Javara Research Inc. - Dallas - PPDS
Houston, Texas, 77054, United States
-
Klinikum der Friedrich Schiller Universität Jena
Jena, Thuringia, 07747, Germany
-
Leids Universitair Medisch Centrum
Leiden, South Holland, 2333 ZA, Netherlands
-
New Horizons Clinical Trials, LLC
Chandler, Arizona, 85224, United States
-
New York-Presbyterian-Queens
New York, New York, 10065, United States
-
Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
Oslo Universitetssykehus HF, Ullevål
Oslo, Oslo, 0524, Norway
-
Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
-
Rutgers New Jersey Medical School
Newark, New Jersey, 07103, United States
-
St. Peter's University Hospital
New Brunswick, New Jersey, 08901, United States
-
St. Thomas' Hospital
London, Surrey, SE1 7EH, United Kingdom
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
-
Södersjukhuset
Stockholm, Stockholms Ian, 118 83, Sweden
-
Temple Perinatal Diagnosis Center
Philadelphia, Pennsylvania, 19140, United States
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
-
Universitetssykehuset Nord Norge
Tromsø, NO-9019, Norway
-
University of Miami Miller School of Medicine
Miami, Florida, 33136, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
Weill Cornell Medicine-New York Presbyterian Hospital
New York, New York, 10065, United States
-
Wright State Physicians Obstetrics & Gynecology
Dayton, Ohio, 45409, United States
-
Yale University School of Medicine
New Haven, Connecticut, 06511, United States
-
Zillan Clinical Research - Gardena
Gardena, California, 90247, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.